Aspira Womens Health Inc
Aspira Women's Health Inc., together with its subsidiaries, discovers, develops, and commercializes of noninvasive AI-powered diagnostic tests for gynecologic diseases in the United States. The company's products include Ova1Plus, a qualitative serum test to assess the likelihood of malignancy in women with an ovarian adnexal mass; Overa, a biomarker test intended to maintain Ova1's high sensitiv… Read more
Market Cap & Net Worth: Aspira Womens Health Inc (AWH)
Aspira Womens Health Inc (NASDAQ:AWH) has a market capitalization of $951.06K ($951.06K) as of March 18, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #36927 globally and #12008 in its home market, demonstrating a -72.31% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Aspira Womens Health Inc's stock price $0.03 by its total outstanding shares 35224300 (35.22 Million).
Aspira Womens Health Inc Market Cap History: 2015 to 2025
Aspira Womens Health Inc's market capitalization history from 2015 to 2025. Data shows change from $951.06 Million to $951.06K (-52.49% CAGR).
Index Memberships
Aspira Womens Health Inc is a constituent of 2 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
NASDAQ Health Care
IXHC
|
$2.24 Trillion | 0.00% | #909 of 976 |
|
NASDAQ Composite
IXIC
|
$33.39 Trillion | 0.00% | #2832 of 3165 |
Weight: Aspira Womens Health Inc's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Aspira Womens Health Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Aspira Womens Health Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
2.70x
Aspira Womens Health Inc's market cap is 2.70 times its annual revenue
0.76x
Higher than industry averageLatest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $951.06 Million | $2.18 Million | -$19.11 Million | 436.87x | N/A |
| 2016 | $501.95 Million | $2.64 Million | -$14.97 Million | 189.99x | N/A |
| 2017 | $1.02 Billion | $3.12 Million | -$10.50 Million | 326.74x | N/A |
| 2018 | $158.51 Million | $3.05 Million | -$11.37 Million | 51.92x | N/A |
| 2019 | $427.98 Million | $4.54 Million | -$14.85 Million | 94.31x | N/A |
| 2020 | $3.55 Billion | $4.65 Million | -$17.63 Million | 762.27x | N/A |
| 2021 | $935.21 Million | $6.81 Million | -$31.71 Million | 137.29x | N/A |
| 2022 | $175.73 Million | $8.18 Million | -$21.57 Million | 21.47x | N/A |
| 2023 | $143.72 Million | $9.15 Million | -$16.69 Million | 15.70x | N/A |
| 2024 | $24.83 Million | $9.18 Million | -$13.09 Million | 2.70x | N/A |
Competitor Companies of AWH by Market Capitalization
Companies near Aspira Womens Health Inc in the global market cap rankings as of March 18, 2026.
Key companies related to Aspira Womens Health Inc by market ranking:
- Thermo Fisher Scientific Inc (NYSE:TMO): Ranked #90 globally with a market cap of $177.20 Billion USD.
- Danaher Corporation (NYSE:DHR): Ranked #151 globally with a market cap of $122.79 Billion USD.
- IDEXX Laboratories Inc (NASDAQ:IDXX): Ranked #466 globally with a market cap of $46.38 Billion USD.
- Lonza Group Ltd (PINK:LZAGF): Ranked #511 globally with a market cap of $41.73 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #90 | Thermo Fisher Scientific Inc | NYSE:TMO | $177.20 Billion | $472.71 |
| #151 | Danaher Corporation | NYSE:DHR | $122.79 Billion | $195.21 |
| #466 | IDEXX Laboratories Inc | NASDAQ:IDXX | $46.38 Billion | $586.98 |
| #511 | Lonza Group Ltd | PINK:LZAGF | $41.73 Billion | $596.13 |
Aspira Womens Health Inc Historical Marketcap From 2015 to 2025
Between 2015 and today, Aspira Womens Health Inc's market cap moved from $951.06 Million to $ 951.06K, with a yearly change of -52.49%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | $951.06K | -96.17% |
| 2024 | $24.83 Million | -82.72% |
| 2023 | $143.72 Million | -18.22% |
| 2022 | $175.73 Million | -81.21% |
| 2021 | $935.21 Million | -73.62% |
| 2020 | $3.55 Billion | +728.40% |
| 2019 | $427.98 Million | +170.00% |
| 2018 | $158.51 Million | -84.46% |
| 2017 | $1.02 Billion | +103.16% |
| 2016 | $501.95 Million | -47.22% |
| 2015 | $951.06 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Aspira Womens Health Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $951.06K USD |
| MoneyControl | $951.06K USD |
| MarketWatch | $951.06K USD |
| marketcap.company | $951.06K USD |
| Reuters | $951.06K USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.